期刊文献+

致敏的树突状细胞治疗对黑色素瘤小鼠体内TNF-α及IL-6水平的影响(英文) 被引量:3

Level of TNF-αand IL-6 in melanoma-bearing mice after treatment by dendritic cells pulsed with tumor cell lysates
下载PDF
导出
摘要 目的 研究致敏的树突状细胞 (DC)治疗后黑色素瘤 (B16 )小鼠体内TNF -α及IL - 6的变化规律。方法 用冻融抗原致敏BALB/C小鼠骨髓来源的DC。ELISA法检测治疗组荷瘤小鼠、荷瘤未治组小鼠及正常小鼠体内TNF -α及IL - 6水平。结果 随时间荷瘤小鼠体内IL - 6水平逐渐升高 ,经治疗后IL - 6水平升高更为显著 ,而荷瘤未治组小鼠TNF -α水平逐渐降低经治疗后TNF -α水平显著升高。结论 经过抗原致敏的DC治疗 ,荷瘤鼠体内TNF -α、IL - 6水平显著升高 ,表明抗原致敏的DC能够增强荷瘤小鼠抗肿瘤免疫反应。 Objective: To investigate the mechanism in melanoma-bearing mice after treatment by dendritic cells' pulsed with tumor cell lysates.Methods:Dendritic cells generated from murine bone marrow were pulsed with B16 tumor lysates 40 BALB/C mice were divided into 3 groups: normal group without therapy, bearing tumor group without therapy, bearing tumor group with therapy. The level of TNF-α and IL-6 was detected in 3 groups by ELISA. Results: The level of the serum IL-6 of bearing tumor mice was higher than that of control group mice ( P <0.01), furthermore the level of the IL-6 of the mice treated with tumor tysate-pulsed DCs was the highest( P <0.01) in three groups. The level of TNF-α of bearing tumor group was lower than that of control group( P <0.0 1), and the TNF-α level of treated group was obviously higher than that of control group and beating tumor group( P <0.01).The level of IL-6 and TNF-α bearing tumor mice in vivo increased obviously after therapy of tumor lysate-pulsed DCs.Conclusions:Tumor lysate-pulsed DCs enhance anti-tumor immunity effect.
出处 《中国现代医学杂志》 CAS CSCD 2004年第13期55-58,62,共5页 China Journal of Modern Medicine
关键词 树突状细胞 肿瘤坏死因子 白细胞介素6 黑色素瘤 dendriticcell tumor necrosis factor interleukin-6 melanoma
  • 相关文献

参考文献11

  • 1Steinma RM, Cohn ZA. Identification of a novel type in peripher -allymphoid organs of mice[ J]. Morphology Quatitation Tissue Distribution. J Exp Med, 1973, 137: 11422.
  • 2Austyn JM. Lymphoid dendritie celia[J]. Immunol, 1987, 62:161.
  • 3Steiman RM. The dendritic cell system and its role in immunogmieity[J]. Annu Rev Immunol, 1991,9: 271.
  • 4Thomas RM. The dendritic cell : origin and differentiation[J].Stem Cells, 1996, 14:196.
  • 5Austyn JM. New insighs into the mobilization and phagccyticactivity of dendritic cells[J]. J Exp Mod, 1996, 183: 1287.
  • 6Steiman RM. The dendritic cell system and its role in immunogenicity[J]. Annu Rev Immunol, 1991 ,9:271.
  • 7Thomas RM. The dendritic cell: origin and differentiation [ J ].Stem Cells, 1996, 14:196.
  • 8Austyn JM. New msighs into the mobilization and phagocyticactivity of dendritic cells[ J]. J Exp Med, 1996,183:1287.
  • 9Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B -cell lymphoma ming autologous antigen -pulsed dendritic cells[J]. Nat Med, 1996, 20) :52 -58.
  • 10Yamanaka R, Yajhna N, Tsuchiya N, et al. Administration of inteaaeukin - 12 and - 18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virm - mediatod tumor complememtary DNA [ J ]. J Neurosu

同被引文献16

  • 1马全,甑林林,范萍,查小明,郑伟,武正炎.MAGE-A3抗原肽负载树突状细胞诱导乳腺癌患者免疫应答的研究[J].中国现代医学杂志,2004,14(24):54-56. 被引量:11
  • 2杨惠祥,王新生,徐勇.负载抗原的树突状细胞诱导特异性抗膀胱癌细胞的效应[J].中华实验外科杂志,2005,22(7):889-889. 被引量:3
  • 3ADAMS S,O'NEILL D,BHARDWAJ N,et al.Recent advances in dendritic cell biology[J].J Clin Immunol,2005,25(2):87-98.
  • 4OGATA K,TAMURA H,YOKOSE N,et al.Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-γ and tumour necrosis-α in patients with myelodyspastic syndromes[J].Br J Haematol,1995,90(1):12-19.
  • 5CHAN SH,KOBAUASHI M,SANTOLI D,et al.Mechanisms of IFN-gamma Induction by natural killer cell stimulatory factor (NKSF/IL-12):role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-12[J].J Immunol,1992,148(1):89-95.
  • 6CUNNINGHAM MO,DHILLON A,WOOD SJ,et al.Reciprocal modulation of glutamate and GABA release may underlie the anticonvulsant effect of phenytoin[J].Neuroscience,2000,95 (2):343-351.
  • 7ZEA LONGA EL,WEINSTEIN PR,CARLSON S,et al.Reversible middle cerebral artery occlusion without craniectomy in rat[J].Stroke,1989,20:84-91.
  • 8BEDERSON JB,PITTS LH,TILES M,et al.Rat middle cerebral artery occlusion:evaluation of the model and development of a neurologic examination[J].Stroke,1986,17:472-476.
  • 9BARONE FC,ARVIN B,WHITE RF,et al.Tunor necrosis factor-a:a mediator of focal ischemia brain injury[J].Stroke,1997,28(6):1233-1244.
  • 10TOUZANI O,BOUTIN H,CHUQUET,ROTHWELL N.Potential mechanisms of interleukin-1 involvement in cerebral ischemia[J].Neuroimmunol,1999,100(1-2):203-215.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部